Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Nuvo Research Inc T.NRI

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s):  NRIFF | NRIFD

Nuvo Research, Inc. is a Canadian specialty pharmaceutical company with manufacturing operations. The Company operates two distinct business units: the Topical Products and Technology (TPT) Group (formerly the Pain Group) and the Immunology Group.
Price: $6.85 | Change: $-0.06 | %Change: -0.87%
Volume: 26,514 | Day High/Low: 6.94/6.80 | 52 Week High/Low: 8.33/1.93
View modes: 
2.5 stars

imo time to take profits

As a longtime Nri shareholder, time to take profits.  rate and reply
2.5 stars

Fabrice Taylor

Has anyone reacted on here to the article by Fabrice Taylor in the Globe and Mail? Normally, I steer clear of biotechs. Here's why I like Nuvo Research    "What kind of a valuation could Nuvo get?...read more
4 stars

RE:Valuation??

Let's see now - 2 of those FDA approved drugs cost shareholders 20% of the company plus untold millions in acquisition costs, their asset value has long since been written off and collectively the...read more
3 stars

RE:GUD

good info. was that the 2nd or 3rd time you have posted it? rock fatigue  rate and reply
3.5 stars

Valuation??

Let's see, 4 FDA approved products, WF10, a potential blockbuster drug ready to announce phase 2 expanded results early in the new year, approximately $25.00 per share in capital expenditures since...read more
3.5 stars

RE:RE:A thought occured to me...

I did keep one share. Should I average down. ?  rate and reply
1 star

RE:RE:A thought occured to me...

That would be pre WW11 ?  rate and reply
4 stars

RE:A thought occured to me...

nuvo was once part of the TSE 300.  that was when the stock price hit $14, or in today's post consolidation valuation, $910/share  rate and reply
3 stars

A thought occured to me...

With the recent price increase in the share price and the larger market cap, we will likely be named to some of the TSX indexes possibly soon, or even named to some high tech funds that specifically...read more
5 stars

RE:RE:GUD

Ok, good fit .  how much would Goodman pay ? He sold Paladin for just over $3 billion. Amounts to about 11 times sales and 7 times book. Paladin had $230 million in cash and $111 million in tax pools...read more
2 stars

RE:RE:GUD

Had you had faith in management, you could have bought below $2 less than a year ago and been up nearly 400 %! Take some good advice. Go to a dentist and ask him to drill out all of that concrete...read more
5 stars

RE:GUD

Here's a better idea: How about Goodman takes the place of the pirates, and watch our stock price actually rally to true value without the clown discount.  rate and reply
0 stars

RE:RE:RE:RE:Short Position

That's what I love about this game. Everyone is invited to the table. Kinda keeps it a bit honest IMO.  I was short yesterday and whooo whooo, covered in the collapse and reversed. Felt like Frederick...read more
3 stars

RE:RE:RE:Short Position

Couldn;t resist eh? GOOD!  rate and reply
5 stars

RE:RE:Short Position

<<. And yes, feel free to call me ignorant.>> OK--,,, you are ignorant---  rate and reply
3 stars

RE:GUD

GUD needs immediate revenues, near term revenues and an all star drug. NRI can provide them with $15 to $20 million per year excluding P2 outside the US. Thats near term. Within a year, P2 will have...read more
0 stars

where now MMs

over 9 or below 7 first? market, a casino a day. cheers, dave.  rate and reply
2.5 stars

RE:GUD

I want $25-$30. You seem to be in the know, can you let him know. I think a bunch of us longs and (not really wrongs) would go for that!  rate and reply
2.5 stars

GUD

Jon Goodman is head of GUD which spun out of Paladin a few months ago. He is the former CEO of Paladin. Gud have about $350 million in cash and are Lookng to build another Paladin. Nuvo would be an...read more
3 stars

RE:RE:RE:Short Position

Anon did the short yesterday. Interestingly, they are the largest buyer and seller today. These are probably the $3 warrants that were used to cover  rate and reply